Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,003 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study.
Lamy A, Jönsson B, Weintraub WS, Zhao F, Chrolavicius S, Bakhai A, Culler S, Gafni A, Lindgren P, Mahoney E, Yusuf S; CURE Economic Group. Lamy A, et al. Among authors: yusuf s. Eur J Cardiovasc Prev Rehabil. 2004 Dec;11(6):460-5. doi: 10.1097/01.hjr.0000152239.28456.36. Eur J Cardiovasc Prev Rehabil. 2004. PMID: 15580055 Clinical Trial.
How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials.
Devereaux PJ, Beattie WS, Choi PT, Badner NH, Guyatt GH, Villar JC, Cinà CS, Leslie K, Jacka MJ, Montori VM, Bhandari M, Avezum A, Cavalcanti AB, Giles JW, Schricker T, Yang H, Jakobsen CJ, Yusuf S. Devereaux PJ, et al. Among authors: yusuf s. BMJ. 2005 Aug 6;331(7512):313-21. doi: 10.1136/bmj.38503.623646.8F. Epub 2005 Jul 4. BMJ. 2005. PMID: 15996966 Free PMC article. Review.
Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation.
Mahoney EM, Mehta S, Yuan Y, Jackson J, Chen R, Gabriel S, Lamy A, Culler S, Caro J, Yusuf S, Weintraub WS; CURE Study Investigators. Mahoney EM, et al. Among authors: yusuf s. Am Heart J. 2006 Jan;151(1):219-27. doi: 10.1016/j.ahj.2005.02.044. Am Heart J. 2006. PMID: 16368322
Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery.
POISE Trial Investigators; Devereaux PJ, Yang H, Guyatt GH, Leslie K, Villar JC, Monteri VM, Choi P, Giles JW, Yusuf S. POISE Trial Investigators, et al. Among authors: yusuf s. Am Heart J. 2006 Aug;152(2):223-30. doi: 10.1016/j.ahj.2006.05.019. Am Heart J. 2006. PMID: 16875901
Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes.
Fox KA, Bassand JP, Mehta SR, Wallentin L, Theroux P, Piegas LS, Valentin V, Moccetti T, Chrolavicius S, Afzal R, Yusuf S; OASIS 5 Investigators. Fox KA, et al. Among authors: yusuf s. Ann Intern Med. 2007 Sep 4;147(5):304-10. doi: 10.7326/0003-4819-147-5-200709040-00005. Ann Intern Med. 2007. PMID: 17785485 Clinical Trial.
2,003 results